These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23643196)

  • 1. The study of DNA methylation in urological cancer: present and future.
    Andrés G; Ashour N; Sánchez-Chapado M; Ropero S; Angulo JC
    Actas Urol Esp; 2013 Jun; 37(6):368-75. PubMed ID: 23643196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
    Larsen LK; Lind GE; Guldberg P; Dahl C
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
    Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers for non-invasive molecular genetic diagnosis of oncourological diseases].
    Mikhaĭlenko DS; Perepechin DV; Apolikhin OI; Efremov GD; Sivkov AV
    Urologiia; 2014; (5):116-20. PubMed ID: 25807773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene methylation and early detection of genitourinary cancer: the road ahead.
    Cairns P
    Nat Rev Cancer; 2007 Jul; 7(7):531-43. PubMed ID: 17585333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
    Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder].
    Friedrich MG; Toma MI; Chun JK; Steuber T; Budäus L; Isbarn H; Huland H
    Urologe A; 2007 Jul; 46(7):761-8. PubMed ID: 17522834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH; Isaacs WB; Bova GS; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA methylation: potential for diagnosis, prognosis and therapy--prediction in oncology].
    Haedicke W; Lesche R
    Verh Dtsch Ges Pathol; 2006; 90():39-45. PubMed ID: 17867578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender matters.
    Köhler CU; Bonberg N; Ahrens M; Behrens T; Hovanec J; Eisenacher M; Noldus J; Deix T; Braun K; Gohlke H; Walter M; Tannapfel A; Tam Y; Sommerer F; Marcus K; Jöckel KH; Erbel R; Cantor CR; Käfferlein HU; Brüning T
    Int J Cancer; 2019 Nov; 145(10):2861-2872. PubMed ID: 31008534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.